Introduction: The New Era of Metabolic Drug Discovery The global landscape of metabolic research has undergone a revolutionary transformation. With obesity affecting over 650 million adults worldwide and type 2 diabetes mellitus (T2DM) reaching pandemic proportions, the demand for novel pharmacological interventions has never been greater . For researchers conducting preclinical and clinical studies, access to […]
Gastrointestinal, Metabolic, and Autoimmune Drug Research: A Preclinical Overview of Mesalamine, Budesonide, Dexilant, Nexium, Domperidone, Rifaximin, Creon, Stelara, and Wegovy
Introduction: The Frontier of Drug Discovery in GI, Metabolic, and Autoimmune Disorders The landscape of gastroenterology, metabolic health, and autoimmunity is undergoing a seismic shift. For researchers and procurement specialists, understanding the bridge between preclinical mechanisms and clinical application is vital. Drugs like Mesalamine and Budesonide have long been the standard for inflammatory bowel conditions, while next-generation biologics like Stelara and metabolic modulators […]